PROAXON
ProAxon develops sodium channel modulators for the treatment of various central nervous system and non-central nervous system diseases.
PROAXON
Industry:
Biotechnology Health Care Pharmaceutical
Address:
London, England, United Kingdom
Country:
United Kingdom
Status:
Active
Similar Organizations
Adenovir Pharma
Adenovir Pharma develops solutions for the treatment of infectious diseases affecting the eyes.
Clevexel Pharma
Clevexel is a pharmaceutical company that develops treatments for the central nervous system, specializing in Parkinson's disease.
Curidium Medica
Curidium Medica identifies medicines and companion diagnostics for the treatment of central nervous system disorders.
Inexia
Inexia aims to develop intranasally administered orexin positive modulators for the treatment of neurological diseases.
Karveel Pharmaceuticals
Karveel Pharmaceuticals develops antibiotics for the treatment of serious drug-resistant infections.
Monument Therapeutics
Monument Therapeutics develops products to treat serious diseases of the central nervous system.
OrganoBalance GmbH
OrganoBalance GmbH develops, produces, and markets medicines used in the treatment of dental and skin bacterial infections.
Santhera Pharmaceuticals
Santhera Pharmaceuticals develops and markets pharmaceutical products for the treatment of mitochondrial and neuromuscular diseases.
THC Pharm
THC Pharm develops drugs & medicinal products for the treatment of multimorbidity, cancer and neurological diseases.
Zogenix
Zogenix develops and commercializes products for the treatment of central nervous system disorders and pain.